👋Hello and welcome to ONCOSCREEN, a €13M flagship project funded by Horizon Europe 🇪🇺 research and innovation actions supporting the implementation of #EU's Mission on Cancer and focusing on the development of new methods and technologies for cancer screening and early detection. Here's a little bit of information about us 👇 ✔️ The ONCOSCREEN project will develop new technologies and methodologies for low-cost colorectal cancer screening and contribute to raising awareness on the disease and its detection. ✔️ The project consortium comprises 38 partners from 15 EU member states and associated countries. It brings together technical solutions partners, medical professionals, cancer research experts, cancer patient associations, and policy makers. ✔️ Only 14% of European citizens participates in cancer screening programmes. There is an urgent need for accurate, non-invasive, and cost-effective screening tests. ONCOSCREEN addresses these challenges by offering innovative solutions to citizens, doctors, and policy makers. ➡️Stay with #ONCOSCREEN’s social channels for more updates throughout the project #horizoneurope #cancerresearch #cancerscreening #technologicalinnovation
ONCOSCREEN
Research Services
A European "shield" against colorectal cancer based on novel, more precise and affordable risk-based screening methods.
Σχετικά με εμάς
The ONCOSCREEN project seeks to develop new methods and technologies for cancer screening and early detection. The core objective of ONCOSCREEN is to enhance citizen awareness, participation, and acceptance of colorectal cancer screening programmes. The ONCOSCREEN Consortium consists of 38 partner organisations representing 15 countries across Europe. The ONCOSCREEN project is funded under the European Union's Horizon Europe research and innovation programme under grant agreement no. 101097036 and is coordinated by EXUS AI Labs. Views and opinions expressed are of the project owner only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
- Κλάδος
- Research Services
- Μέγεθος εταιρείας
- 11-50 εργαζόμενοι
- Έδρα
- Athens
- Τύπος
- Μη κερδοσκοπικός οργανισμός
- Ιδρύθηκε
- 2022
- Ειδικότητες
Τοποθεσίες
-
Κύρια
Athens, GR
Ενημερώσεις
-
✳️ #ONCOSCREEN Introduction series ✳️ Our next partner is Europacolon Portugal (ECPT) With expertise in stakeholder engagement, communication and dissemination activities, ECPT will be instrumental in increasing the impact and potential of proposed ONCOSCREEN technologies and methodologies and training end users. ECPT will provide its support and knowledge in the task related to health economics. Furthermore it will contribute to designing citizen awareness campaigns for colorectal cancer screening programmes, supporting efforts in increasing participation and knowledge of citizens about colorectal cancer. ➡️ Learn more about ECPT: https://lnkd.in/er7HfTe4 #HorizonEurope #EUCancerPlan #MissionCancer #CancerScreening #CancerResearch #EU4Health #HealthUnion #CancerAwareness #CRCScreening #ONCOSCREEN.
-
-
🔤 The A-Z of ONCOSCREEN 🔤 B is for Biopsy At #ONCOSCREEN, biopsy plays a vital role in colorectal cancer (CRC) detection and prevention. During a colonoscopy, tissue samples are taken for in-depth analysis to identify cancerous or precancerous cells. With the help of AI-assisted colonoscopy training, ONCOSCREEN is improving the accuracy and efficiency of biopsies. By integrating AI into medical training, clinicians can better detect and assess lesions, ensuring early and precise diagnosis. Why biopsies matter in ONCOSCREEN: ✅ Essential for confirming CRC and precancerous conditions. ✅ Enhanced by AI to improve detection accuracy. ✅ Supports timely treatment and better patient outcomes. ✅ Helps reduce missed diagnoses, leading to improved care. Stay tuned as we continue unveiling the A-Z of ONCOSCREEN! ➡️ Read more about AI-assisted colonoscopy training in ONCOSCREEN: https://lnkd.in/eZrryA-e
-
-
Yesterday our Project partners Universidade do Minho and Europacolon Portugal attended an event for World Cancer day held at Instituto Português de Oncologia do Porto (IPO-Porto) "Cancer turned our lives upside down... Cancer challenges us, scientists, by constantly evolving, pushing us to develop ever-more precise diagnostic tools. Each breakthrough brings hope, but also reveals new complexities, turning out work into a relentless race against time" #DiaMundialdoCancro #UnidosPorCadaUm #WorldCancerDay #UnitedByUnique #CRCAwareness #HorizonEurope #Ehealth #CancerResearch
-
-
🟠 World Cancer Day: Early Detection Saves Lives! 🟠 This #WorldCancerDay, let's talk about the power of prevention. Colorectal cancer is one of the most common cancers, but with early screening, it’s also one of the most preventable. 🔬 ONCOSCREEN is committed to advancing colorectal cancer screening across Europe, ensuring more people have access to life-saving early detection. Screening can catch cancer in its early stages—often before symptoms appear—leading to better outcomes and healthier lives. ✅ Get screened. ✅ Spread awareness. ✅ Take action today! Together, we can close the care gap. 💙 #ONCOSCREEN #ColorectalCancer #EarlyDetectionSavesLives #HorizonEurope #Ehealth
-
-
🎉 600 Followers! 🎉 We’re thrilled to share that the #ONCOSCREEN Project has reached 600 followers! 🚀 A huge THANK YOU to all of you for your support and commitment to advancing cancer screening and early detection. We’re excited to continue sharing groundbreaking research, innovations, and insights with this incredible community. Let’s keep the momentum going—together, we can make a real impact! 💙🔬 #MissonCancer #CancerResearch #CRCAwareness #Colorectalcancer #Ehealth #HorizonEurope
-
-
Ο χρήσης ONCOSCREEN το αναδημοσίευσε
🌍 Exciting News from MERIC! 🌟DAVOS 2025! The beginning of great projects and amazing partnerships We are proud to announce the presence of the Medical Education Research and Innovation Center (MERIC) at the prestigious World Economic Forum in Davos! As global leaders gather to discuss transformative solutions for a healthier and more equitable future, MERIC will contribute its expertise in health innovation, medical education, and research. Together, we aim to address global health challenges and drive meaningful change. Stay tuned as we share insights and outcomes from our participation at this influential event. Let’s shape the future of healthcare, together! #Davos2025 #HealthInnovation #GlobalImpact #MERIC #MedicalEducation #ResearchAndInnovation#ONCOSCREEN#ONCODIR#Desipoc#GRIPonMASH
-
-
Ο χρήσης ONCOSCREEN το αναδημοσίευσε
BEIA company participated in the ROHEALTH event on January 22-23, 2025. During the event, working groups on various specializations took place. Our company participated in the E-HEALTH group on the health field and disseminated the SHIFT-HUB, MOBILISE EU Project, ONCOSCREEN, ONCODIR projects. Find out more: https://lnkd.in/dcChsxjD
-
-
ONCOSCREEN: PERSONALIZED SCREENING What if colorectal cancer screening was tailored to your unique characteristics? That's exactly what the #ONCOSCREEN project is making possible! ➡️ Risk-Based Screening 👉 Every person is different, and so is their risk of developing cancer. 👉 ONCOSCREEN uses advanced analytics to personalize screening programs, ensuring that each individual receives the right care at the right time. #ONCOCREEN aims to ensure that all populations, even the most vulnerable, have access to care tailored to their needs. Learn more at https://oncoscreen.health. #ONCOSCREEN #ColorectalCancer #Innovation #Health #Prevention #HorizonEurope #MissionCancer #CancerScre
-
-
🔤The A-Z of ONCOSCREEN🔤 A is for Artificial Intelligence At #ONCOSCREEN, Artificial Intelligence (AI) is revolutionizing our approach to colorectal cancer (CRC) detection and diagnosis. By integrating AI with eye-tracking technology, we analyse how pathologists examine whole slide images (WSIs) to diagnose CRC. This research enables us to develop advanced training tools that mirror expert diagnostic processes, accelerating the learning curve for trainees and enhancing diagnostic precision. We are deeply committed to ensuring that our AI systems respect patient autonomy, privacy, and equality. By adhering to strict data protection regulations and actively mitigating algorithmic biases, we strive to provide fair and transparent AI-driven healthcare solutions that serve all individuals equitably. Why AI matters in ONCOSCREEN: ✅ Provides insights into expert diagnostic processes, enhancing medical education. ✅ Prioritizes patient rights, data privacy, and unbiased healthcare delivery. ✅ Speeds up diagnosis, giving patients answers faster. ✅ Enhances accuracy, minimizing false positives and negatives. ✅ Supports tailored treatment plans by analysing patient-specific data. Stay tuned as we continue to unveil the A-Z of ONCOSCREEN. ➡️To read more about the use of AI in the ONCOSCREEN Project, visit: https://lnkd.in/ei6BwxT7